All Articles

Histone lactylation in hepatocellular carcinoma: a key epigenetic hub linking metabolic reprogramming and the immune microenvironment

Multi-task neural network enhanced by data augmentation and ROI optimization for prognosis and MVI prediction in HCC using contrast-enhanced CT

Review of advances in FOLFOX-HAIC for conversion, neoadjuvant, and adjuvant therapy in hepatocellular carcinoma

Cordycepin alleviates oxaliplatin-induced fatty liver disease

Kupffer cells and monocyte-derived macrophages in the pathogenesis and treatment of hepatocellular carcinoma

Reconstructing strategies for precision diagnosis and treatment of liver cancer based on multi-modal data

The role of “treatment unfeasibility” in the multiparametric, multidisciplinary, and expert evaluation of HCC patients

Metabolic reprogramming and the tumor microenvironment in hepatocellular carcinoma: mechanisms and therapeutic targeting

The evolving role of contrast-enhanced ultrasound in hepatocellular carcinoma: from diagnosis to therapeutic monitoring

Application of ex vivo liver perfusion in hepatoma research

Converse therapeutic hierarchy in hepatocellular carcinoma

Molecular characteristics of fatty acid metabolic reprogramming in hepatocellular carcinoma and their implications for immunotherapy

Exploring the molecular pathology and tumor microenvironment in gastric cancer liver metastasis

Rewiring the tumor microenvironment in hepatocellular carcinoma: mechanism-driven integration of immunotherapy and locoregional strategies

Controlled attenuation parameter factors and steatosis grading in metabolic dysfunction-associated steatotic liver disease

Emerging potential of CAR-NK cell therapy for hepatocellular carcinoma: current advances and translational challenges

Functional cure of chronic hepatitis B virus infection: current therapeutic regimens

A baseline-lymphocyte-subset nomogram for predicting severe immune-related adverse events in hepatocellular carcinoma patients receiving TACE plus immunotherapy